Is fetal pulse oximetry a waste of time? Riveting results from an important trial presented at the 26th annual SMFM meeting in Miami in February suggest just that?and seemingly shatter the whole premise behind fetal pulse oximetry: that it might either improve perinatal outcome or lower cesarean delivery rates.
Is fetal pulse oximetry a waste of time? Riveting results from an important trial presented at the 26th annual SMFM meeting in Miami in February suggest just that-and seemingly shatter the whole premise behind fetal pulse oximetry: that it might either improve perinatal outcome or lower cesarean delivery rates.
The practice of using fetal oximetry to measure fetal oxygen saturation during labor was already on pretty shaky ground when National Institute of Child Health and Human Development (NICHD) MFMU Network researchers decided it was time to assess the device's effectiveness in a large, prospective well-designed trial. After all, in the wake of the FDA's conditional approval of the oximetry device in May 2000, the dystocia rate had unexpectedly and inexplicably doubled, pointed out Bethesda investigator, S. L. Bloom. Moreover, in a subsequent ACOG Committee Opinion, the organization had refused to endorse the new technology.
Aiming to assess the technology in "a real-world setting," the researchers set out to measure whether a clinician's awareness of fetal oxygen saturation values used in conjunction with continuous electronic fetal monitoring is associated with the condition of the newborn or linked to a significant change in the overall cesarean delivery rate (that includes C/S performed specifically for dystocia and nonreassuring fetal heart rate).
Bloom SL for the NICHD MFMU Network, Bethesda, Maryland. The MFMU Network randomized trial of fetal pulse oximetry. Am J Obstet Gynecol. 2005;193(6 suppl):S2. (Abstract 1)
Inactivated COVID-19 vaccines in pregnancy: No impact on neonatal outcome, study finds
November 28th 2023A comprehensive cohort study explored the impact of inactivated COVID-19 vaccines administered within 3 months before conception, revealing reassuring findings that neonatal outcomes, including preterm birth and NICU admission, remain unaffected.
Read More
Late-preterm antenatal corticosteroid treatment in twin pregnancies and newborn morbidity
November 27th 2023A recent retrospective cohort study found that administering antenatal corticosteroids from 34 to 36 weeks of gestation did not decrease composite neonatal respiratory morbidity in twin pregnancies, challenging conventional practices for this high-risk population.
Read More
The impact of WIC enrollment on breastfeeding rates: A comprehensive study
November 21st 2023Explore the findings of a recent study, revealing that enrollment in the Special Supplemental Nutritional Program for Women, Infants, and Children may influence breastfeeding decisions, shedding light on disparities and suggesting the need for targeted initiatives to enhance breastfeeding rates among low-income mothers.
Read More